Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesARA-290 (Cibinetide): 2026 Evidence & Neuropathic Pain Relief
Unpack the newest 2026 evidence surrounding ARA-290 (Cibinetide), focusing on its impact on neuropathic pain, inflammation, and potential revised clinical recommendations.
PeptidesARA-290 (Cibinetide): Latest Evidence &
Discover the most recent clinical evidence on ARA-290 (Cibinetide), focusing on its applications in neuropathy and anti-inflammatory pathways, with updated insights for 2026.
PeptidesARA-290 (Cibinetide) in the UK: Availability
Understanding ARA-290's UK availability and cost is vital. This guide covers legal status, sourcing, pricing, and safety for those considering Cibinetide.
PeptidesARA-290 for Healthy Ageing After 50 in 2026: An
Could ARA-290 be a valuable tool for healthy ageing? This expert analysis focuses on its benefits and considerations for individuals over 50, exploring its anti-inflammatory and reparative properties.
PeptidesARA-290 Dosing & Protocols: Optimising
Understanding the nuances of ARA-290 (Cibinetide) dosing is crucial for maximising its therapeutic benefits. This guide explores optimal protocols, titration, and cycle strategies.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.